Staar Surgical Co. (NASDAQ:STAA) shares saw unusually-high trading volume on Friday . Approximately 132,528 shares traded hands during mid-day trading, an increase of 58% from the previous session’s volume of 83,963 shares.The stock last traded at $8.35 and had previously closed at $8.24.

STAA has been the subject of several research reports. Canaccord Genuity reaffirmed a “hold” rating and issued a $7.00 target price on shares of Staar Surgical in a research report on Thursday, May 12th. Stephens downgraded Staar Surgical from an “overweight” rating to an “equal weight” rating in a research report on Thursday, May 12th. Zacks Investment Research raised Staar Surgical from a “strong sell” rating to a “hold” rating in a research report on Wednesday, July 13th. Benchmark Co. raised Staar Surgical from a “hold” rating to a “buy” rating and set a $6.00 target price for the company in a research report on Wednesday, May 18th. Finally, William Blair reaffirmed a “market perform” rating on shares of Staar Surgical in a research report on Thursday. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $6.50.

The company’s market capitalization is $340.78 million. The company has a 50-day moving average price of $6.21 and a 200 day moving average price of $6.58.

Staar Surgical (NASDAQ:STAA) last issued its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.05) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.05). The business had revenue of $21 million for the quarter, compared to analyst estimates of $19.88 million. The business’s revenue was up 12.4% on a year-over-year basis. On average, analysts predict that Staar Surgical Co. will post ($0.31) EPS for the current year.

In other Staar Surgical news, Director Richard A. Meier sold 25,000 shares of the firm’s stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of $5.35, for a total transaction of $133,750.00. Following the completion of the sale, the director now owns 27,149 shares in the company, valued at approximately $145,247.15. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, major shareholder Broadwood Partners Lp acquired 9,313 shares of the stock in a transaction on Tuesday, May 17th. The shares were acquired at an average price of $5.23 per share, with a total value of $48,706.99. The disclosure for this purchase can be found here.

An institutional investor recently raised its position in Staar Surgical stock. Mutual of America Capital Management LLC raised its position in shares of Staar Surgical Co. (NASDAQ:STAA) by 0.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 216,682 shares of the company’s stock after buying an additional 1,299 shares during the period. Mutual of America Capital Management LLC owned 0.54% of Staar Surgical worth $1,547,000 at the end of the most recent quarter.

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.